Zabedosertib
Pharmaceutical compound
From Wikipedia, the free encyclopedia
Zabedosertib (BAY 1834845) is an experimental drug which acts as a selective inhibitor of the enzyme interleukin‐1 receptor‐associated kinase 4 (IRAK4). It has antiinflammatory effects and is being researched for possible applications in treating inflammatory conditions of the skin.[1][2][3]
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C21H22F3N3O4S |
| Molar mass | 469.48 g·mol−1 |
| 3D model (JSmol) | |
| |
| |